Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial
Many benefit from a tailored course of treatments, planned following consultation and aligned to individual goals and clinical considerations
Lifestyle-based supplements (DHEA in some cases of low ovarian reserve) are used judiciously and under specialist supervision
Glenn for his time and for the important work he's doing to protect consumers
74 Witschi et al
US$ 21.85
US$ 20.43
US$ 21.38
US$ 24.53
US$ 20.69
US$ 23.20
